Importance of mold allergy in asthma

Jay M Portnoy1, Charles S Barnes, Kevin Kennedy

  • 1Section of Allergy, Asthma, and Immunology, Children's Mercy Hospitals and Clinics, 2401 Gillham Road, Kansas City, MO 64108, USA. jportnoy@cmh.edu

Insights

Fungal exposure

Area of Science:

  • Environmental science
  • Allergy and immunology
  • Respiratory medicine

Background:

  • Fungal exposure is controversially linked to asthma development and symptom exacerbation.
  • Ubiquitous environmental fungi necessitate a thorough review of the evidence.
  • Limited evidence currently supports a causal link between fungal exposure and asthma development.

Purpose of the Study:

  • To critically review the scientific evidence on the association between fungal exposure and asthma.
  • To explore potential mechanisms linking fungi to asthma development and symptom triggers.
  • To assess the strength of evidence for fungal exposure as a cause or trigger of asthma.

Main Methods:

  • Systematic review of existing epidemiological and clinical studies.
  • Analysis of proposed biological mechanisms for fungal-asthma interactions.
  • Evaluation of the correlation between fungal exposure levels and asthma symptoms.

Main Results:

  • Limited evidence supports fungi causing asthma development; mechanisms remain unclear.
  • Stronger evidence indicates fungal exposure triggers symptoms in individuals with asthma.
  • Demonstrated correlations between exposure and symptoms, though some remain speculative.
  • Asthma symptom severity is dose-dependent on fungal exposure.

Conclusions:

  • While fungal exposure's role in asthma development is not definitively proven, it is a significant trigger for asthma symptoms.
  • Understanding dose-dependent responses offers potential for targeted interventions.
  • Guidance on creating healthy indoor environments can help manage asthma in relation to fungal exposure.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma